These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10415369)

  • 1. The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats.
    Kuroda S; Janelidze S; Siesjö BK
    Brain Res; 1999 Jul; 835(2):148-53. PubMed ID: 10415369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A.
    Yoshimoto T; Kristián T; Hu B; Ouyang YB; Siesjö BK
    Brain Res; 2002 Apr; 932(1-2):99-109. PubMed ID: 11911866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat.
    Yoshimoto T; Uchino H; He QP; Li PA; Siesjö BK
    Brain Res; 2001 Apr; 899(1-2):148-58. PubMed ID: 11311876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury.
    Bochelen D; Rudin M; Sauter A
    J Pharmacol Exp Ther; 1999 Feb; 288(2):653-9. PubMed ID: 9918571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted clinical efficacy of cyclosporin A on rat transient middle cerebral artery occlusion.
    Matsumoto S; Isshiki A; Watanabe Y; Wieloch T
    Life Sci; 2002 Dec; 72(4-5):591-600. PubMed ID: 12467900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia.
    Li PA; Uchino H; Elmér E; Siesjö BK
    Brain Res; 1997 Apr; 753(1):133-40. PubMed ID: 9125440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats.
    Nito C; Kamiya T; Ueda M; Arii T; Katayama Y
    Brain Res; 2004 May; 1008(2):179-85. PubMed ID: 15145754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 ameliorates oxidative damage and protects rat brain following transient focal cerebral ischemia.
    Nito C; Ueda M; Inaba T; Katsura K; Katayama Y
    Neurol Res; 2011 Oct; 33(8):881-9. PubMed ID: 22004713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia.
    Yoshimoto T; Siesjö BK
    Brain Res; 1999 Aug; 839(2):283-91. PubMed ID: 10519051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat.
    Uchino H; Elmér E; Uchino K; Li PA; He QP; Smith ML; Siesjö BK
    Brain Res; 1998 Nov; 812(1-2):216-26. PubMed ID: 9813336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of an immunosuppressant agent on diffusion/perfusion mismatch in transient focal ischemia.
    Ebisu T; Mori Y; Katsuta K; Fujikawa A; Matsuoka N; Aoki I; Umeda M; Naruse S; Tanaka C
    Magn Reson Med; 2004 Jun; 51(6):1173-80. PubMed ID: 15170837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
    Nakai A; Kuroda S; Kristián T; Siesjö BK
    Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M; Kaminska B
    Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window.
    Maeda M; Furuichi Y; Ueyama N; Moriguchi A; Satoh N; Matsuoka N; Goto T; Yanagihara T
    J Cereb Blood Flow Metab; 2002 Oct; 22(10):1205-11. PubMed ID: 12368659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release.
    Shichinohe H; Kuroda S; Abumiya T; Ikeda J; Kobayashi T; Yoshimoto T; Iwasaki Y
    Brain Res; 2004 Mar; 1001(1-2):51-9. PubMed ID: 14972653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome C to cytoplasm.
    Domañska-Janik K; Buzañska L; Dłuzniewska J; Kozłowska H; Sarnowska A; Zabłocka B
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):50-9. PubMed ID: 14969736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat.
    Noto T; Ishiye M; Furuich Y; Keida Y; Katsuta K; Moriguchi A; Matsuoka N; Aramori I; Goto T; Yanagihara T
    Brain Res Mol Brain Res; 2004 Sep; 128(1):30-8. PubMed ID: 15337315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia.
    Arii T; Kamiya T; Arii K; Ueda M; Nito C; Katsura KI; Katayama Y
    Neurol Res; 2001 Oct; 23(7):755-60. PubMed ID: 11680517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition.
    Uchino H; Minamikawa-Tachino R; Kristián T; Perkins G; Narazaki M; Siesjö BK; Shibasaki F
    Neurobiol Dis; 2002 Aug; 10(3):219-33. PubMed ID: 12270685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus (FK506) reduces ischemia-induced hippocampal damage in rats: a 7- and 30-day study.
    Giordani F; Benetolli A; Favero-Filho LA; Lima KC; Cestari Junior L; Milani H
    Braz J Med Biol Res; 2003 Apr; 36(4):495-502. PubMed ID: 12700828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.